Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Deployment and Validation of Rho - An Opportunistic Osteoporosis Screening Software-as-a-Medical Device

NCT05245851 is registered in ClinicalTrials.gov with 16 Bit Inc. as lead sponsor.

NCT NCT05245851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05245851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Deployment and Validation of Rho - An Opportunistic Osteoporosis Screening Software-as-a-Medical Device
Lead sponsor
16 Bit Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 21, 2022
Completion date
October 1, 2023
Enrollment
1,146 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

low bone density